Tracker

CDSCO approvals

CDSCO's list of new drug and clinical trial approvals holds 217 permission letters dated 2019, from January 6, 2019 to December 31, 2019. GCT is the most common kind of permission, with 84. Each row gives the company, product, kind of permission, date and a link to the letter, and CDSCO's file number where its text gives it.

From CDSCO's CT Approvals list, read . Each product links to CDSCO's PDF of its letter. The date is the one CDSCO gives on its list; the file number is printed in the letter. Not stated: file number on 10 rows. The file number is not read from 72 scanned letters: we read a letter's text, not its image.

The kinds of permission are CDSCO's own. FDC is fixed-dose combination (CDSCO's guidance for its Subject Expert Committees, page 13); GCT is global clinical trial (CDSCO's FAQs on the New Drugs and Clinical Trials Rules, page 8); SND is Subsequent New Drugs (CDSCO's Citizen's Charter, page 2); rDNA is recombinant Deoxyribonucleic Acid (CDSCO's FAQs on the New Drugs and Clinical Trials Rules, page 3, which that page writes r-DNA).

December 2019

November 2019

October 2019

September 2019

August 2019

July 2019

June 2019

May 2019

April 2019

March 2019

February 2019

January 2019